Targeted Therapies

Abstract

The objective of this research is for WCM, together with NYP Brooklyn Methodist Hospital (BMH) and Columbia University Medical Center (CUMC), to participate in the PCCTC as a multisite Clinical Research Site. Our overall aim is to translate our prostate cancer (PC) expertise in targeted therapies, PC imaging, immunotherapy, and correlative science into novel therapeutic approaches that can be tested in multi-institutional studies performed within the PCCTC. We intend to bring novel agents and new biomarker-driven trials directly to PC patients, including underrepresented minorities and veterans.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Oct 01, 2023
Accession Number
AD1219065

Entities

People

  • David M. Nanus
  • Devan-ann Louissaint
  • May Ann Todd
  • Scott T Tagawa

Organizations

  • Cornell University

Tags

DTIC Thesaurus Topics

  • Abstracts
  • Androgen Receptors
  • Biological Markers
  • Clinical Trials
  • Data Analysis
  • Health Services
  • Immunotherapy
  • Lymphocytes
  • Medical Personnel
  • Minority Groups
  • Neoplasms
  • Prostate
  • Prostate Cancer
  • Social Media
  • Standards
  • Therapy
  • Universities

Fields of Study

  • Medicine

Readers

  • Oncology
  • Oncology and Biomarker-Based Cancer Detection.
  • Research Science/Academic Research

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech